Effects of sulfur containing amino acids on iron and nitric oxide stimulated catecholamine oxidation.
Taurine is a free amino acid found in high concentrations in tissues containing catecholamines. The ability of taurine and its metabolic precursors to inhibit or stimulate catecholamine oxidation and subsequent quinone formation was examined. Ferric chloride was used as the catalyzing agent to stimulate L-dopa or norepinephrine oxidation and NO donors were also examined for their actions to stimulate quinone formation. Taurine attenuated iron-stimulated quinone formation from catecholamines suggesting that it may function as an endogenous antioxidant. Several other sulfur-containing amino acids (homocysteic acid, cysteine sulfinic acid and SAM) were found to inhibit catecholamine oxidation. Among other amino acids tested, homocysteine had biphasic effects; attenuating L-dopa oxidation catalyzed by ferric chloride and potentiating norepinephrine's oxidation catalyzed by both ferric chloride and sodium nitroprusside (SNP). Homotaurine and homocysteine (1 or 10 mM) greatly stimulated SNP-induced norepinephrine oxidation. Homotaurine potentiated quinone formation in the presence of ferric iron and this effect was attenuated by desferroxamine. In order to exclude a possible NO/iron interaction in SNP's oxidizing action, SIN-1 chloride, a specific NO-donor, was tested as an oxidizing agent. The failure of desferroxamine or taurine to attenuate SIN-1 oxidation of norepinephrine suggests that peroxynitrite-mediated oxidation was likely the dominant mechanism. Our results show that endogenous sulfur containing amino acids, like taurine, could serve a protective role to reduce cellular damage associated with both NO and metal-stimulated catecholamine oxidation.
Biasetti
M
M
Department of Pharmacodynamics, College of Pharmacy, JHMHC Box 100487, University of Florida, Gainesville, FL 32610, U.S.A.
Dawson
R
R
D000603:Amino Acids, Sulfur / Q000737:chemistry*; D002395:Catecholamines / Q000737:chemistry*; D002712:Chlorides; D005290:Ferric Compounds / Q000737:chemistry; D007980:Levodopa / Q000737:chemistry; D008981:Molsidomine / Q000031:analogs & derivatives / Q000737:chemistry; D009569:Nitric Oxide / Q000037:antagonists & inhibitors / Q000737:chemistry*; D009599:Nitroprusside / Q000737:chemistry; D009638:Norepinephrine / Q000737:chemistry; D010084:Oxidation-Reduction; D013654:Taurine / Q000737:chemistry
D000603:Amino Acids, Sulfur; D002395:Catecholamines; D002712:Chlorides; D005290:Ferric Compounds; D009599:Nitroprusside; D013654:Taurine; D009569:Nitric Oxide; D007980:Levodopa; C002385:linsidomine; D008981:Molsidomine; C024555:ferric chloride; D009638:Norepinephrine